本季度信息
根据华润医药旗下控股子公司华润双鹤公布的截至2026年9月30日止九个月未经审计财务数据，营收约80.66亿元，同比去年同期的84.02亿元下降约4.00%。同期净利润录得约13.07亿元，相较上年同期的13.99亿元下降约6.51%。报告期内，华润双鹤的现金及现金等价物净增加额约为2.11亿元，上年同期为净减少6.30亿元，期末现金及现金等价物余额为21.19亿元。 财务数据显示，华润双鹤的总资产由上年末173.96亿元增长至2026年9月30日的191.33亿元，总负债从46.30亿元增至57.70亿元，所有者权益为133.64亿元，较去年末增加约4.71%。目前，华润医药透过其附属公司合计持有华润双鹤60.26%的权益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.